140 related articles for article (PubMed ID: 18397716)
21. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
23. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[TBL] [Abstract][Full Text] [Related]
24. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[TBL] [Abstract][Full Text] [Related]
25. Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis.
Doi T; Masaki T; Shiraki N; Kawai T; Yorioka N
Clin Nephrol; 2008 Jun; 69(6):433-5. PubMed ID: 18538119
[TBL] [Abstract][Full Text] [Related]
26. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Onuma S; Kimura S; Ito E
Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
[TBL] [Abstract][Full Text] [Related]
27. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Fujinaga S; Hirano D; Nishizaki N; Someya T; Ohtomo Y; Ohtsuka Y; Shimizu T; Kaneko K
Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
[TBL] [Abstract][Full Text] [Related]
28. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
29. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
30. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Tsubouchi Y; Fukuda W; Kawahito Y; Kohno M; Wada M; Ishino H; Hamaguchi M; Yamamoto A; Kadoya M; Niimi M; Yoshikawa T
Mod Rheumatol; 2008; 18(1):91-5. PubMed ID: 18159569
[TBL] [Abstract][Full Text] [Related]
31. Incidence of relapse and frequently relapsing/steroid-dependent nephrotic syndrome in Chinese children with steroid-sensitive nephrotic syndrome: A cohort study.
Ying D; Yu N; Lin Z; Chen L; Rong L; Wu J; Jiang M; Jiang X
Nephrology (Carlton); 2023 Sep; 28(9):477-484. PubMed ID: 37254566
[TBL] [Abstract][Full Text] [Related]
32. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.
Inoki Y; Nishi K; Osaka K; Kaneda T; Akiyama M; Sato M; Ogura M; Kamei K
Pediatr Nephrol; 2024 Aug; 39(8):2393-2401. PubMed ID: 38267591
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B; Babu BG; Mahapatra TK
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[TBL] [Abstract][Full Text] [Related]
34. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
36. Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study.
Takahashi T; Okamoto T; Sato Y; Yamazaki T; Hayashi A; Aoyagi H; Ueno M; Kobayashi N; Uetake K; Nakanishi M; Ariga T
Pediatr Nephrol; 2019 Jan; 34(1):87-96. PubMed ID: 30141179
[TBL] [Abstract][Full Text] [Related]
37. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.
Imaizumi T; Kawasaki Y; Matsuura H; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Aug; 22(8):1215-8. PubMed ID: 17347835
[TBL] [Abstract][Full Text] [Related]
39. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
